A Retrospective, Single-Center, Non-Randomized, Cross-Sectional Comparative Effectiveness Study Evaluating Surface Area Reduction, Volume Reduction and Closure Rates in Acute and Chronic Wounds Managed with Grafix® versus EpiFix®
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Placental-derived mesenchymal stem cell therapy Osiris Therapeutics (Primary) ; DHACM
- Indications Wounds
- Focus Therapeutic Use
- 19 Jan 2017 According to Osiris Therapeutics media release, the study and results have been published in the peer-reviewed journal Wound Repair and Regeneration.
- 06 May 2016 New trial record
- 03 May 2016 According to MiMedx media release, this study does not meet any of the established criteria. As this study lacks an adequate or relevant controls and inadequate clinical study standards.